InvestorsHub on MSN
Ambry Genetics launches whole genome sequencing tests to improve rare disease diagnosis
Ambry Genetics, a wholly owned subsidiary of Tempus AI (NASDAQ:TEM), has introduced GenomeNext and GenomeReveal, a new whole ...
If you had looked at Myriad Genetics in October 2025, seen bullish talk about genomics, AI and precision medicine, then ...
(NASDAQ: TEM), today announced the launch of GenomeNext™ and GenomeReveal™, a comprehensive whole genome sequencing (WGS) ...
Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing ...
Scientists accidentally discovered a microscopic organism with a genetic code that breaks a rule researchers thought was ...
This study presents RovHer, a heritability-optimized scoring method for estimating the functional impact of rare variants, which is applied to the UK Biobank to demonstrate its ability to enrich for ...
Myriad Genetics, SOPHiA GENETICS and AstraZeneca are collaborating to advance Myriad’s prostate cancer genomic instability ...
Susan Dymecki, the George Fabyan Professor of Genetics in the Field of Comparative Pathology in the Blavatnik Institute at ...
SOPHiA GENETICS (NASDAQ: SOPH) and Myriad Genetics, Inc., (NASDAQ: MYGN) today announce a collaboration to advance new ...
Sunshine Genetics enrolls first Florida families, launching expanded newborn screening pilot program
The Florida Institute for Pediatric Rare Diseases (IPRD) at Florida State University has enrolled its first families in the ...
Microbial genetics is the study of the mechanisms of heritable information in microorganisms, including bacteria, archaea, viruses and some protozoa and fungi.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results